BioPhausia

Contact
biophausia.se
+46-8-4076430

BioPhausia AB

Blasieholmsgatan 2
111 48 Stockholm
Sweden
+46-8-4076430
biophausia.se
Contact
Profile News
Contact

About BioPhausia

BioPhausia is a Specialty Pharma company in the Nordic area. The company provides cost-effective pharmaceuticals and focuses on three fields: generic products, niche products and original drugs. BioPhausia focuses on marketing and sales. BioPhausia has no research program at the present time.

Read more about BioPhausia
Facts about BioPhausia
  • Industry : Pharma

News about BioPhausia

BioPhausia

29-Aug-2011 | business & finance

Medivir subsidiary BioPhausia AB sells generics business

Medivir reports that on 25 August, BioPhausia AB reached an agreement to sell its generics business in the form of subsidiary BMM Pharma AB to Bluefish ...

Read news
BioPhausia

12-Apr-2011 | business & finance

Medivir to acquire BioPhausia

Medivir AB announced an offer to acquire all shares of BioPhausia AB (publ)  and all Listed Warrants (as defined below) issued by BioPhausia (the “Offer ...

Read news
BioPhausia

28-Sep-2010 | business & finance

BioPhausia focuses and sells OTC products to Meda for SEK 190 million

BioPhausia signed an agreement to sell its portfolio of OTC products to Meda for a total of SEK 190 million, plus the value of the inventory. The Company ...

Read news
BioPhausia

17-Aug-2010 | business & finance

BioPhausia streamlines in order to focus on Nordic market

The Board of BioPhausia has decided to start the process of streamlining the Company's operations and products with the aim of strengthening profitability ...

Read news
BioPhausia

16-Feb-2010 | people

Claes Thulin leaving BioPhausia

BioPhausia's CEO Claes Thulin is leaving his post in order to pursue entrepreneurial activities. The change of CEO is supported by the Board, which has ...

Read news
Show more news about BioPhausia

Here you will find BioPhausia AB